Severe insomnia can lead to fatigue, poor concentration, low mood and other problems. Long-term insomnia can also trigger cardiovascular disease, anxiety, depression and other diseases. Effective anti-insomnia drugs play an irreplaceable role in maintaining modern public health.

At Protheragen, our anti-insomnia API portfolio includes melatonin receptor agonists, GABA modulators, orexin receptor antagonists, and other advanced compounds that target the different pathways involved in sleep regulation. All of our APIs are manufactured in GMP-certified facilities, ensuring high purity, stability, and compliance with global pharmaceutical standards.

Protheragen offers a full range of anti-insomnia APIs to support the development of effective treatment options for sleep disorders.